- Report
- November 2024
- 450 Pages
Global
From €3793EUR$3,995USD£3,199GBP
- Report
- October 2024
- 1800 Pages
Global
From €3793EUR$3,995USD£3,199GBP
- Report
- October 2024
- 196 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- July 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- September 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- March 2025
- 175 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- January 2025
- 186 Pages
Global
From €4742EUR$4,995USD£4,000GBP
- Newsletter
- March 2025
- 88 Pages
Global
€1251EUR$1,318USD£1,055GBP
- Report
- January 2023
- 315 Pages
Global
From €4556EUR$4,799USD£3,843GBP
- Report
- April 2018
- 97 Pages
Global
From €15189EUR$16,000USD£12,812GBP
- Report
- March 2023
- 356 Pages
Global
From €3323EUR$3,500USD£2,803GBP
€4747EUR$5,000USD£4,004GBP
- Report
- January 2024
- 145 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- November 2023
- 630 Pages
Global
From €9019EUR$9,500USD£7,607GBP
- Report
- February 2024
- 115 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- April 2023
- 120 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- March 2024
- 200 Pages
Global
From €3940EUR$4,150USD£3,323GBP
- Report
- November 2022
- 33 Pages
Global
€11629EUR$12,250USD£9,809GBP
- Book
- February 2024
- 640 Pages

Pancreatic cancer is a type of cancer that affects the pancreas, an organ located in the abdomen. It is one of the most aggressive and deadly forms of cancer, with a five-year survival rate of only 9%. It is the fourth leading cause of cancer-related death in the United States.
Treatment for pancreatic cancer typically involves a combination of surgery, chemotherapy, and radiation therapy. Surgery is the most common treatment, and is used to remove tumors and surrounding tissue. Chemotherapy and radiation therapy are used to kill cancer cells that may remain after surgery.
The oncology market for pancreatic cancer is highly competitive, with many companies developing new treatments and therapies. Companies are focusing on developing targeted therapies, immunotherapies, and combination therapies to improve outcomes for patients.
Companies in the pancreatic cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more